News & Updates
Filter by Specialty:
Four-drug pill beats three separate meds in difficult-to-treat hypertension
For individuals with difficult-to-treat hypertension who are struggling with three separate medications, a single pill that combines four blood pressure (BP)-lowering drugs may help with BP control, as shown in the phase III QUADRO trial.
Four-drug pill beats three separate meds in difficult-to-treat hypertension
07 Sep 2024
SGLT-2 inhibitors may prevent dementia in adults with T2D
Initiation of sodium-glucose cotransporter-2 (SGLT-2) inhibitors results in a 35-percent reduced risk of dementia compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in individuals with type 2 diabetes (T2D) aged 40–69 years, according to a study. In addition, greater benefits are seen with longer treatment duration.
SGLT-2 inhibitors may prevent dementia in adults with T2D
07 Sep 2024
Tapinarof safe, efficacious for moderate-to-severe AD in children, adults
Treatment with tapinarof cream 1% once daily demonstrates significant efficacy with a favourable safety profile among adults and children with moderate-to-severe atopic dermatitis (AD), a study has shown.
Tapinarof safe, efficacious for moderate-to-severe AD in children, adults
06 Sep 2024
Dupilumab prevents atopic march progression in children with AD
Use of dupilumab effectively lowers the risk of atopic march progression as opposed to conventional immunomodulatory therapies in paediatric patients with atopic dermatitis (AD), reports a recent study.
Dupilumab prevents atopic march progression in children with AD
06 Sep 2024
Wolbachia-infected male Aedes aegypti mosquito releases stem dengue incidence
Releasing Wolbachia-infected male Aedes (A) aegypti mosquitoes were associated with a reduction in dengue incidence rates, a synthetic control study in Singapore has shown.
